LONDON (Thomson Financial) - Ardana PLC said the US Food and Drug Administration (FDA) has granted orphan drug status for ARD-07, the oral growth hormone Secretagogue (GHS), which Ardana is developing as a diagnostic for growth hormone deficiency in adults.
